Creative Medical Technology Holdings Provides Update on ImmCelz® FDA Application prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Creative Medical Technology Holdings Provides Update on ImmCelz® FDA Application prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Creative Medical Technology Holdings files Patent on Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells Utilizing ImmCelz® Cellular Immunotherapy
Clinical Stage Cell Therapy Company Reports Concurrent Modulation of T Regulatory Cells and Tolerogenic Dendritic Cells using Adoptive Cellular Therapy
News provided by
Share this article
Share this article
PHOENIX, Dec. 10, 2020 /PRNewswire/ Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company s ImmCelz
® product at generating what is termed in the field of immunology as infectious tolerance.
Using an animal model of rheumatoid arthritis, investigators demonstrated administration of ImmCel